Search

everythinglearnresearchcommunity

for

Search:↓

People with early onset androgenetic alopecia may have a higher chance of metabolic syndrome, especially dyslipidemia.

Vitamin D levels are not correlated with chronic hair loss in Telogen Effluvium patients.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Early detection and treatment are crucial to prevent irreversible hair loss in Lichen Planopilaris.

Microneedling shows promise for hair loss but needs more research.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Microneedle patches improve drug delivery for skin treatments and cosmetic enhancements.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

Lack of certain nutrients may contribute to hair loss and proper diet or supplements could improve it.

Many young men with hair loss have low levels of vitamin D and B12.

Women with a certain type of hair loss had lower levels of a hormone called prolactin compared to healthy women.

People with chronic hair shedding had much lower vitamin D levels compared to healthy people.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Researchers found four distinct fibroblast types in human skin, which could help in treating wounds and fibrotic diseases.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Proteomic analysis can identify genetic differences in mouse hair, helping understand hair defects and variations.

In vitro skin models are improving but still need more innovation to fully replicate human skin.

Epidermal stem cells on a special membrane helped mice regrow full skin with hair and functions.

Menopause significantly affects skin health and conditions.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Menopause can cause oral health issues like dry mouth and burning sensations.

Wnt/β-catenin signaling is important for keeping skin cell attachment structures stable.

Vitamin D3 is a safe and effective alternative to steroids for treating alopecia areata, with fewer side effects.

Higher platelet counts and activators in PRP improve hair density and thickness in treating hair loss.

Chronic stress can reduce skin pigmentation.

About 43% of people in Europe have had a skin condition in the past year, with fungal infections, acne, and eczema being the most common.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

A new classification system for skin cysts was proposed to improve diagnosis.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.